BIOMARIN PHARMACEUTICAL INC Annual Costs and Expenses in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Costs and Expenses history and growth rate from 2010 to 2023.
  • Biomarin Pharmaceutical Inc Costs and Expenses for the quarter ending September 30, 2024 was $632M, a 14.7% increase year-over-year.
  • Biomarin Pharmaceutical Inc Costs and Expenses for the twelve months ending September 30, 2024 was $2.43B, a 11.7% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Costs and Expenses for 2023 was $2.26B, a 16.2% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Costs and Expenses for 2022 was $1.95B, a 0.93% increase from 2021.
  • Biomarin Pharmaceutical Inc annual Costs and Expenses for 2021 was $1.93B, a 1.3% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.26B +$315M +16.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 $1.95B +$17.9M +0.93% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 $1.93B +$24.7M +1.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $1.9B +$99.4M +5.51% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $1.8B +$190M +11.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $1.61B +$286M +21.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $1.33B -$592M -30.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $1.92B +$920M +91.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $1B +$158M +18.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 $842M +$138M +19.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
2013 $704M +$93.6M +15.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $611M +$136M +28.6% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 $475M +$99.5M +26.5% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-26
2010 $376M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.